Suchergebnisse - "Zhao, Jinge"

PubPharm (97)

1

Predicting abiraterone efficacy in advanced prostate cancer : Insights from marker of proliferation Ki67

enthalten in: The Prostate | 2024

von Zhao, F. | Zhao, J. | Wei, X. | +17

2

Memory/active T cell activation is associated with immunotherapeutic response in fumarate hydratase-deficient renal cell carcinoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Chen, J. | Hu, X. | Zhao, J. | +36

3

Genomic and Evolutionary Characterization of Concurrent Intraductal Carcinoma and Adenocarcinoma of the Prostate

enthalten in: Cancer research | 2024

von Zhao, J. | Xu, N. | Zhu, S. | +34

4

Preparation and application of PD-L1 targeted polypeptide hydrogel

enthalten in: Europäisches Patentamt | 2023

von WANG XIN | ZHAO JINGE | WANG YUZHI

5

The therapeutic efficacy of radical prostatectomy and external beam radiation therapy in patients with different pathological patterns of prostate cancer

enthalten in: Asian journal of surgery | 2023

von Zhao, J. | Sun, G. | Zhao, F. | +15

6

Neuroendocrine differentiation predicts the therapeutic efficacy of abiraterone and docetaxel as first-line therapy in metastatic castration-resistant prostate cancer

enthalten in: Journal of cancer research and clinical oncology | 2023

von Xu, N. | Zhao, J. | Zhao, F. | +26

7

Retraction to the prognostic value of the pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer

enthalten in: Annals of translational medicine | 2023

von Wang, Z. | Liu, H. | Zhao, J. | +13

RetractionOf: Ann Transl Med. 2023 Mar 15;11(5):201. - PMID 37007568

8

Safety and efficacy associated with single-fraction high-dose-rate brachytherapy in localized prostate cancer : a systematic review and meta-analysis

enthalten in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al | 2023

von Zeng, H. | Dai, J. | Cao, D. | +9

9

Genomic and transcriptomic features between primary and paired metastatic fumarate hydratase-deficient renal cell carcinoma

enthalten in: Genome medicine | 2023

von Liang, J. | Sun, G. | Pan, X. | +27

10

Genomic and transcriptomic features between primary and paired metastatic fumarate hydratase–deficient renal cell carcinoma

enthalten in: Genome medicine | 2023

von Liang, J. | Sun, G. | Pan, X. | +27

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]